Published in Cancer on May 17, 2012
The benefits and harms of breast cancer screening: an independent review. Br J Cancer (2013) 3.43
Overdiagnosis in breast cancer screening: the importance of length of observation period and lead time. Breast Cancer Res (2013) 2.11
Arguments against mammography screening continue to be based on faulty science. Oncologist (2014) 1.00
Overdiagnosis: epidemiologic concepts and estimation. Epidemiol Health (2015) 0.84
Overdiagnosis of breast cancer in the Norwegian Breast Cancer Screening Program estimated by the Norwegian Women and Cancer cohort study. BMC Cancer (2013) 0.82
Implications of Overdiagnosis: Impact on Screening Mammography Practices. Popul Health Manag (2015) 0.77
Evaluation of health benefits and harms of the breast cancer screening programme in the Basque Country using discrete event simulation. BMC Cancer (2015) 0.77
Pitfalls in accurate estimation of overdiagnosis: implications for screening policy and compliance. Breast Cancer Res (2013) 0.77
Evaluation issues in the Swedish Two-County Trial of breast cancer screening: An historical review. J Med Screen (2016) 0.75
Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. Gastroenterology (2008) 15.86
Once-only flexible sigmoidoscopy screening in prevention of colorectal cancer: a multicentre randomised controlled trial. Lancet (2010) 15.50
Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. CA Cancer J Clin (2008) 12.90
American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography. CA Cancer J Clin (2007) 12.19
American Cancer Society guideline for the early detection of prostate cancer: update 2010. CA Cancer J Clin (2010) 6.45
American Cancer Society guideline for the early detection of cervical neoplasia and cancer. CA Cancer J Clin (2002) 5.56
Mammography service screening and mortality in breast cancer patients: 20-year follow-up before and after introduction of screening. Lancet (2003) 5.40
A breast cancer prediction model incorporating familial and personal risk factors. Stat Med (2004) 5.30
Swedish two-county trial: impact of mammographic screening on breast cancer mortality during 3 decades. Radiology (2011) 5.17
Absolute numbers of lives saved and overdiagnosis in breast cancer screening, from a randomized trial and from the Breast Screening Programme in England. J Med Screen (2010) 4.72
Worldwide variations in colorectal cancer. CA Cancer J Clin (2009) 4.71
Guidelines for colonoscopy surveillance after polypectomy: a consensus update by the US Multi-Society Task Force on Colorectal Cancer and the American Cancer Society. Gastroenterology (2006) 4.57
Tamoxifen-induced reduction in mammographic density and breast cancer risk reduction: a nested case-control study. J Natl Cancer Inst (2011) 3.73
Supplemental oxygen impairs detection of hypoventilation by pulse oximetry. Chest (2004) 3.55
MRI breast screening in high-risk women: cancer detection and survival analysis. Breast Cancer Res Treat (2014) 3.46
Predictive accuracy of the Liverpool Lung Project risk model for stratifying patients for computed tomography screening for lung cancer: a case-control and cohort validation study. Ann Intern Med (2012) 3.45
Guidelines for colonoscopy surveillance after polypectomy: a consensus update by the US Multi-Society Task Force on Colorectal Cancer and the American Cancer Society. CA Cancer J Clin (2006) 3.21
American Cancer Society lung cancer screening guidelines. CA Cancer J Clin (2013) 3.16
The randomized trials of breast cancer screening: what have we learned? Radiol Clin North Am (2004) 3.06
A national survey of primary care physicians' methods for screening for fecal occult blood. Ann Intern Med (2005) 3.01
Preventing cancer, cardiovascular disease, and diabetes: a common agenda for the American Cancer Society, the American Diabetes Association, and the American Heart Association. Circulation (2004) 2.91
CT screening for lung cancer in the UK: position statement by UKLS investigators following the NLST report. Thorax (2011) 2.88
Tamoxifen and breast density in women at increased risk of breast cancer. J Natl Cancer Inst (2004) 2.87
The impact of organized mammography service screening on breast carcinoma mortality in seven Swedish counties. Cancer (2002) 2.85
The efficacy and safety of pain management before and after implementation of hospital-wide pain management standards: is patient safety compromised by treatment based solely on numerical pain ratings? Anesth Analg (2005) 2.83
Standardized colonoscopy reporting and data system: report of the Quality Assurance Task Group of the National Colorectal Cancer Roundtable. Gastrointest Endosc (2007) 2.82
American Cancer Society Guideline for human papillomavirus (HPV) vaccine use to prevent cervical cancer and its precursors. CA Cancer J Clin (2007) 2.81
Evaluation of abdominal ultrasonography mass screening for hepatocellular carcinoma in Taiwan. Hepatology (2014) 2.79
Counterpoint: Overdiagnosis in breast cancer screening. J Am Coll Radiol (2014) 2.75
The Gothenburg Breast Screening Trial. Cancer (2003) 2.59
Single reading with computer-aided detection for screening mammography. N Engl J Med (2008) 2.58
Type 2 diabetes and hepatocellular carcinoma: A cohort study in high prevalence area of hepatitis virus infection. Hepatology (2006) 2.49
International Association for the Study of Lung Cancer Computed Tomography Screening Workshop 2011 report. J Thorac Oncol (2012) 2.45
Colorectal cancer screening: a comparison of 35 initiatives in 17 countries. Int J Cancer (2008) 2.41
Baseline faecal occult blood concentration as a predictor of incident colorectal neoplasia: longitudinal follow-up of a Taiwanese population-based colorectal cancer screening cohort. Lancet Oncol (2011) 2.41
Insights from the breast cancer screening trials: how screening affects the natural history of breast cancer and implications for evaluating service screening programs. Breast J (2014) 2.37
Sequential design approaches for bioequivalence studies with crossover designs. Pharm Stat (2008) 2.33
Guideline implementation for breast healthcare in low-income and middle-income countries: overview of the Breast Health Global Initiative Global Summit 2007. Cancer (2008) 2.28
Overdiagnosis, sojourn time, and sensitivity in the Copenhagen mammography screening program. Breast J (2006) 2.24
Mammographic breast density: comparison of methods for quantitative evaluation. Radiology (2015) 2.22
Overdiagnosis in mammographic screening for breast cancer in Europe: a literature review. J Med Screen (2012) 2.21
Effectiveness of fecal immunochemical testing in reducing colorectal cancer mortality from the One Million Taiwanese Screening Program. Cancer (2015) 2.19
Community-based multiple screening model: design, implementation, and analysis of 42,387 participants. Cancer (2004) 2.17
Systematic review: surveillance for breast cancer in women treated with chest radiation for childhood, adolescent, or young adult cancer. Ann Intern Med (2010) 2.17
Overdiagnosis in breast cancer screening: the importance of length of observation period and lead time. Breast Cancer Res (2013) 2.11
Clinical impacts of mammalian target of rapamycin expression in human colorectal cancers. Hum Pathol (2013) 2.09
A population-based study on the immediate and prolonged effects of the 1999 Taiwan earthquake on mortality. Ann Epidemiol (2003) 2.08
Identifying minimally acceptable interpretive performance criteria for screening mammography. Radiology (2010) 2.06
Correlates of underutilization of colorectal cancer screening among U.S. adults, age 50 years and older. Prev Med (2003) 2.05
The benefit of mass eradication of Helicobacter pylori infection: a community-based study of gastric cancer prevention. Gut (2012) 2.05
A novel case-control design to estimate the extent of over-diagnosis of breast cancer due to organised population-based mammography screening. Int J Cancer (2014) 2.00
Critical research gaps and translational priorities for the successful prevention and treatment of breast cancer. Breast Cancer Res (2013) 1.92
Guideline implementation for breast healthcare in low- and middle-income countries: early detection resource allocation. Cancer (2008) 1.90
Guidelines for colonoscopy surveillance after cancer resection: a consensus update by the American Cancer Society and the US Multi-Society Task Force on Colorectal Cancer. Gastroenterology (2006) 1.89
Modelling the cumulative risk of a false-positive screening test. Stat Methods Med Res (2010) 1.87
Promoting early detection tests for colorectal carcinoma and adenomatous polyps: a framework for action: the strategic plan of the National Colorectal Cancer Roundtable. Cancer (2002) 1.87
Breast cancer in limited-resource countries: an overview of the Breast Health Global Initiative 2005 guidelines. Breast J (2006) 1.85
Influence of annual interpretive volume on screening mammography performance in the United States. Radiology (2011) 1.81
Colorectal cancer screening barriers and facilitators in older persons. Prev Med (2009) 1.73
A perspective from countries using organized screening programs. Cancer (2004) 1.72
Relationships between disease activity and serum and fecal biomarkers in patients with Crohn's disease. Clin Gastroenterol Hepatol (2008) 1.70
Mammographic tumor features can predict long-term outcomes reliably in women with 1-14-mm invasive breast carcinoma. Cancer (2004) 1.70
Effect of baseline breast density on breast cancer incidence, stage, mortality, and screening parameters: 25-year follow-up of a Swedish mammographic screening. Cancer Epidemiol Biomarkers Prev (2010) 1.69
Mammographic parenchymal patterns and self-reported soy intake in Singapore Chinese women. Cancer Epidemiol Biomarkers Prev (2002) 1.67
Revised colorectal screening guidelines: joint effort of the American Cancer Society, U.S. Multisociety Task Force on Colorectal Cancer, and American College of Radiology. Radiology (2008) 1.60
Breast screening saves lives. BMJ (2009) 1.58
Mean sojourn time and effectiveness of mortality reduction for lung cancer screening with computed tomography. Int J Cancer (2008) 1.54
Progression rates of colorectal cancer by Dukes' stage in a high-risk group: analysis of selective colorectal cancer screening. Cancer J (2004) 1.53
Colonoscopy surveillance after polypectomy and colorectal cancer resection. Am Fam Physician (2008) 1.52
Carcinoma ex pleomorphic adenoma: a comprehensive review of clinical, pathological and molecular data. Head Neck Pathol (2011) 1.52
Lung cancer risk prediction: a tool for early detection. Int J Cancer (2007) 1.51
Better prediction of prognosis for patients with nasopharyngeal carcinoma using primary tumor volume. Cancer (2004) 1.51
Progression of pre-hypertension, stage 1 and 2 hypertension (JNC 7): a population-based study in Keelung, Taiwan (Keelung Community-based Integrated Screening No. 9). J Hypertens (2006) 1.51
Ultrasound screening and risk factors for death from hepatocellular carcinoma in a high risk group in Taiwan. Int J Cancer (2002) 1.48
Mammographic screening and "overdiagnosis". Radiology (2011) 1.48
Uptake of prostate-specific antigen testing for early prostate cancer detection in Sweden. Int J Cancer (2011) 1.47
Emerging technologies in screening for colorectal cancer: CT colonography, immunochemical fecal occult blood tests, and stool screening using molecular markers. CA Cancer J Clin (2003) 1.44
Breast cancer in limited-resource countries: early detection and access to care. Breast J (2006) 1.43
Increased risk of stroke after trigeminal neuralgia--a population-based follow-up study. Cephalalgia (2011) 1.43
Time-dependent effects on survival in breast carcinoma: results of 20 years of follow-up from the Swedish Two-County Study. Cancer (2004) 1.42
Prevention and early detection clinical trials: opportunities for primary care providers and their patients. CA Cancer J Clin (2003) 1.41
Remission, relapse, and metastasis/death of small hepatocellular carcinoma treated with percutaneous ethanol injection. Cancer J (2006) 1.39